Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

Creative Commons License

TURAN N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., ...More

CHINESE JOURNAL OF CANCER RESEARCH, vol.27, no.4, pp.408-416, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 4
  • Publication Date: 2015
  • Doi Number: 10.3978/j.issn.1000-9604.2015.08.03
  • Journal Name: CHINESE JOURNAL OF CANCER RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.408-416
  • Keywords: Pancreatic adenocarcinoma, adjuvant chemotherapy (adjuvant CT), adjuvant radiotherapy, SINGLE-INSTITUTION EXPERIENCE, RANDOMIZED CONTROLLED-TRIAL, SEER REGISTRY DATA, PHASE-III, RADIATION-THERAPY, FOLINIC ACID, CANCER, CHEMOTHERAPY, RADIOTHERAPY, GEMCITABINE
  • Gazi University Affiliated: Yes

Abstract

Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC).